X0202 3 2005-09-20 0 0001086688 INTARCIA THERAPEUTICS, INC ITCA 0001237289 SANDELL SCOTT D 1119 ST. PAUL STREET BALTIMORE MD 21202 0 0 1 0 Series D Convertible Preferred Common Stock 2381944 I See Note 2 Series E Convertible Preferred Common Stock 1687964 I See Note 2 The Issuer's Preferred Stock will automatically convert into Common Stock at the closing of the IPO at the rate of .0833333 per share. The Reporting Person is a general partner of NEA Partners 10, Limited Partnership, which is the sole general partner of New Enterprise Associates 10, Limited Partnership ("NEA 10"), the beneficial owner of the securities. The Reporting Person disclaims beneficial ownership, within the meaning of Section 16 of the Securities Exchange Act of 1934, as amended, of such portion of the securities held by NEA 10, except to the extent of his pecuniary interest therein. In addition to the shares reported herein, NEA Ventures 2003, L.P. owns Series D Preferred Stock convertible into 5,208 shares of Common Stock of the Issuer. The Reporting Person does not have voting nor dispositive powers over such shares. The Reporting Person disclaims beneficial ownership, within the meaning of Section 16 of the Securities Exchange Act of 1934, as amended, of such portion of these shares in which the Reporting Person has no actual pecuniary interest therein. Louis S. Citron 2005-09-20